Case Studies in Bayesian Methods for Biopharmaceutical CMC Case Studies in Bayesian Methods for Biopharmaceutical CMC
Chapman & Hall/CRC Biostatistics Series

Case Studies in Bayesian Methods for Biopharmaceutical CMC

    • 64,99 €
    • 64,99 €

Description de l’éditeur

The subject of this book is applied Bayesian methods for chemistry, manufacturing, and control (CMC) studies in the biopharmaceutical industry. The book has multiple authors from industry and academia, each contributing a case study (chapter). The collection of case studies covers a broad array of CMC topics, including stability analysis, analytical method development, specification setting, process development and optimization, process control, experimental design, dissolution testing, and comparability studies. The analysis of each case study includes a presentation of code and reproducible output. This book is written with an academic level aimed at practicing nonclinical biostatisticians, most of whom have graduate degrees in statistics.

• First book of its kind focusing strictly on CMC Bayesian case studies

• Case studies with code and output

• Representation from several companies across the industry as well as academia

• Authors are leading and well-known Bayesian statisticians in the CMC field

• Accompanying website with code for reproducibility

• Reflective of real-life industry applications/problems

GENRE
Science et nature
SORTIE
2022
15 décembre
LANGUE
EN
Anglais
LONGUEUR
354
Pages
ÉDITIONS
CRC Press
TAILLE
30,5
Mo
Applied Meta-Analysis with R and Stata Applied Meta-Analysis with R and Stata
2021
Dose-Exposure-Response Modeling Dose-Exposure-Response Modeling
2026
Machine Learning for Microbiome Statistics Machine Learning for Microbiome Statistics
2026
Advanced Statistical Analytics for Health Data Science with SAS and R Advanced Statistical Analytics for Health Data Science with SAS and R
2025
Group Sequential and Adaptive Methods for Clinical Trials Group Sequential and Adaptive Methods for Clinical Trials
2025
R for Health Technology Assessment R for Health Technology Assessment
2025